This course has expired. View available courses.
Endocrinology
Injectable Therapy in the Vulnerable Older Adult (CPD)
The COVID-19 pandemic has created significant challenges for people living with diabetes. Some patients have thrived with the increased emphasis of self-management, where other vulnerable populations have struggled with a decrease in support in maintaining glycaemic control and optimising management.
This patient case will review the clinical considerations of a vulnerable older adults with type 2 diabetes who is currently using insulin.
DURATION
30 min
PROFESSION
Specialist
# OF CREDITS
1
ACCREDITATION
CPD Certificate
EXPIRY DATE
2023-08-05
The COVID-19 pandemic has created significant challenges for people living with diabetes. Some patients have thrived with the increased emphasis of self-management, where other vulnerable populations have struggled with a decrease in support in maintaining glycaemic control and optimising management.
This patient case will review the clinical considerations of a vulnerable older adults with type 2 diabetes who is currently using insulin.
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.
Faculty
Dipesh Patel, PhD, FRCP
David Strain, MD, FRCP, MBChB
Learning objectives
Upon successful completion of this continuing education module, the participant will be better able to:
- Determine the management of hyperglycaemia in an older adult with type 2 diabetes currently using basal insulin
- Discuss the role of frailty on diabetes management
- Review the role of the diabetes management team and interprofessional collaboration to improve outcomes in older adults with type 2 diabetes
Accreditation
This CPD activity has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 1 category 1 (external) CPD credit(s).
Individual participants should only record the number of hours they attend.